相关实验视频

Updated: Jun 8, 2025

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

对非小细胞肺癌骨转移的新见解:机制和疗法

Man Xue¹, Li Ma¹, Pengpeng Zhang²

¹Department of Oncology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.

International journal of biological sciences

|November 4, 2024

概括

骨转移是非小细胞肺癌 (NSCLC) 死亡的主要原因. 了解分子途径是开发NSCLC骨转移新疗法和改善患者存活率的关键.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症转移癌症转移

背景情况:

骨转移是非小细胞肺癌 (NSCLC) 的常见死亡原因,影响30%-40%的患者.
骨转移中的骨相关事件 (SREs) 显著降低了生存率和生活质量 (QoL).
目前的向骨的药物 (BTA) 提供了有限的预后改善,尽管减少了SREs.

研究的目的:

为提供关于非小细胞肺癌 (NSCLC) 骨转移的全面审查.
阐明驱动NSCLC骨转移的分子途径和调节机制.
讨论当前的临床治疗方法,并确定对新型治疗策略的需求.

主要方法:

对非小细胞肺癌 (NSCLC) 骨转移研究的文献综述.
分析瘤细胞与骨微环境之间的分子相互作用.
综合关于信号通路和涉及转移的分泌因素的信息.

主要成果:

骨转移是一个复杂的,多步骤的过程.
瘤细胞与骨微环境广泛相互作用.
信号通路和分泌因子之间的交叉是转移进展的关键.

结论:

了解NSCLC骨转移的分子基础对于开发有效疗法至关重要.
向瘤-骨微环境相互作用可能提供新的治疗途径.
对监管机制的进一步研究可以改善临床管理和患者的治疗结果.

关键词:

骨转移的发生.针对骨的药物是指向骨的药物.非小细胞肺癌是非小细胞肺癌.信号通道的信号通道.

更多相关视频

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells

Published on: June 23, 2022

相关概念视频

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...